Treatment of epidermal growth factor receptor inhibitor-induced skin toxicities: do the data support the current practice?

被引：0
|
作者：
Cotliar, Jonathan [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
来源：
SUPPORTIVE CARE IN CANCER | 2011年 / 19卷 / 10期
关键词：
TRIAL; CANCER; IMPACT;
D O I：
10.1007/s00520-011-1234-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：2
相关论文
共 50 条
  • [31] Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events
    Singer, Sean
    Tan, Sally Y.
    Dewan, Anna K.
    Davids, Matthew
    LaCasce, Ann S.
    Treon, Steven P.
    LeBoeuf, Nicole R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (06) : 1271 - 1281
  • [32] Regulation of Chloride Channels by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced α-Defensin 5
    Uemura, Ippei
    Takahashi-Suzuki, Natsuko
    Kita, Fumiya
    Kobayashi, Masaki
    Yamada, Takehiro
    Iseki, Ken
    Satoh, Takashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (01) : 159 - 165
  • [33] A systematic review of epidermal growth factor receptor tyrosine kinase inhibitor-induced heart failure and its management
    Mohammad Nawaf AlShatnawi
    Rzan Atef Shawashreh
    Mohammed Ashraf Sunoqrot
    Ali Rezeq Yaghi
    The Egyptian Journal of Internal Medicine, 2022, 34
  • [34] A systematic review of epidermal growth factor receptor tyrosine kinase inhibitor-induced heart failure and its management
    AlShatnawi, Mohammad Nawaf
    Shawashreh, Rzan Atef
    Sunoqrot, Mohammed Ashraf
    Yaghi, Ali Rezeq
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01):
  • [35] Fibroblast growth factor receptor inhibitor-induced hyperphosphatemia: Lessons for the nephrologist
    Attieh, Rose Mary
    Upadrista, Pratap
    Levy, Anna T.
    Jhaveri, Kenar D.
    CLINICAL NEPHROLOGY, 2024, 103 (01) : 12 - 18
  • [36] Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab
    Coquart, N.
    Karam, A.
    Metges, J. -P.
    Misery, L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2010, 137 (04): : 306 - 307
  • [37] Epidermal Growth Factor Receptor Inhibitor Induced Trichomegaly and Poliosis
    Goyal, Sunali
    Uwaydat, Sami H.
    OPHTHALMOLOGY, 2018, 125 (02) : 294 - 294
  • [38] Management of Epidermal Growth Factor Inhibitor-Induced Papulopustular Rash: The Dermatologist's Role
    Sanmartin Jimenez, O.
    ACTAS DERMO-SIFILIOGRAFICAS, 2015, 106 (06): : 447 - 447
  • [39] Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Gefitinib: Implications for Pulmonary and Hepatic Toxicities
    Li, Xiaohai
    Kamenecka, Theodore M.
    Cameron, Michael D.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (10) : 1736 - 1742
  • [40] Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
    Tan, Eng Hooi
    Chan, Alexandre
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) : 1658 - 1666
12345